Cell Surface Markers Market Worth $769 Million by 2023 - Exclusive Report by MarketsandMarkets™
According to market research report, "Cell Surface Markers Market by Product (Antibody, PCR Array), Source (Mice, Rat), Cell Type (T cells, B cells, NK cell), Application (Research (Stem Cell, Immunology), Clinical (Oncology, Hematology)), and End User (Hospitals) - Global Forecast to 2023", is valued at an estimated USD 520 million in 2018 and is projected to reach USD 769 million by 2023, growing at a CAGR of 8.1% during the forecast period. The growth of this market is driven by factors such as the high global prevalence of cancer, growth in stem cell and neurobiology research, and the increasing funding for life sciences research.
The cell surface markers market is projected to reach USD 769 million by 2023, at a CAGR of 8.1%. Factors such as the increasing funding for life sciences research, high global prevalence of cancer, and growth in stem cell and neurobiology research are expected to drive the growth of this market in the coming years.
Browse in-depth TOC on "Cell Surface Markers Market"
91 - Tables
40 - Figures
140 - Pages
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=216278622
The cell surface markers market, by cell type, is segmented into T cell surface markers, B cell surface markers, NK cell surface markers, monocyte cell surface markers, and other cell types.
In 2018, the T cell surface markers segment is expected to account for the largest share of the cell surface markers market. The increasing use of these cell surface markers in research and diagnostics is expected to fuel the growth of this segment.
On the basis of end user, the cell surface markers market is segmented into academic & research institutes, hospitals & clinical testing laboratories, and pharmaceutical & biotechnology companies. In 2018, the academic & research institutes segment is expected to account for the largest share of the cell surface markers market.
The growing use of cell surface markers in cancer, stem cell, and HIV research; increasing number of cancer and stem cell research projects across the globe; and the rising public-private funding for cell surface marker-based research are the major factors driving the growth of this end-user segment.
English
Arabic
Français
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian